Inhibition of allergic bronchial asthma by thrombomodulin is mediated by dendritic cells

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 1, 2011, Pages 31-42

  Takagi, Takehiro ^a   Taguchi, Osamu ^a   Toda, Masaaki ^a   Ruiz, Daniel Boveda ^a   Bernabe, Paloma Gil ^a   D'Alessandro Gabazza, Corina N ^a   Miyake, Yasushi ^a   Kobayashi, Tetsu ^a   Aoki, Shinya ^a   Chiba, Fumiko ^a   Yano, Yutaka ^a   Conway, Edward M ^b   Munesue, Seiichi ^c   Yamamoto, Yasuhiko ^c   Yamamoto, Hiroshi ^c   Suzuki, Koji ^a   Takei, Yoshiyuki ^a   Morser, John ^a,d   Gabazza, Esteban C ^a  

^a MIE UNIVERSITY   (Japan)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c KANAZAWA UNIVERSITY   (Japan)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Coagulation; Dendritic cells; Tolerance

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 5; OVALBUMIN; RECOMBINANT THROMBOMODULIN;

ALLERGIC ASTHMA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LUNG FUNCTION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ANIMALS; ASTHMA; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, CELLULAR; MICE; RECOMBINANT PROTEINS; THROMBOMODULIN;

EID: 78650799395     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201001-0107OC     Document Type: Article

References (47)

1. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344:350-362.
2. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-178.
3. Burchell JT, Strickland DH, Stumbles PA. The role of dendritic cells and regulatory T cells in the regulation of allergic asthma. Pharmacol Ther 2010;125:1-10.
4. Langlois RA, Legge KL. Respiratory dendritic cells: mediators of tolerance and immunity. Immunol Res 2007;39:128-145.
5. GeurtsvanKessel CH, Lambrecht BN. Division of labor between dendritic cell subsets of the lung. Mucosal Immunol 2008;1:442-450.
6. Naik SH. Demystifying the development of dendritic cell subtypes, a little. Immunol Cell Biol 2008;86:439-452.
7. Steinman RM. Dendritic cells: understanding immunogenicity. Eur J Immunol 2007;37:S53-S60.
8. Hume DA. Macrophages as APC and the dendritic cell myth. J Immunol 2008;181:5829-5835.
9. Ito T, Liu YJ, Kadowaki N. Functional diversity and plasticity of human dendritic cell subsets. Int J Hematol 2005;81:188-196.
10. Ardavin C. Origin, precursors and differentiation of mouse dendritic cells. Nat Rev Immunol 2003;3:582-590.
11. Niessen F, Schaffner F, Furlan-Freguia C, Pawlinski R, Bhattacharjee G, Chun J, Derian CK, Andrade-Gordon P, Rosen H, Ruf W. Dendritic cell par1-s1p3 signalling couples coagulation and inflammation. Nature 2008;452:654-658.
12. Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, Ousman SS, Fernald GH, Gerlitz B, Robinson WH, Baranzini SE, et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 2008;451:1076-1081.
13. Wagers SS, Norton RJ, Rinaldi LM, Bates JH, Sobel BE, Irvin CG. Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J Clin Invest 2004;114: 104-111.
14. Matthay MA, Clements JA. Coagulation-dependent mechanisms and asthma. J Clin Invest 2004;114:20-23.
15. Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 1997;78:386-391.
16. Van de Wouwer M, Conway EM. Novel functions of thrombomodulin in inflammation. Crit Care Med 2004;32:S254-S261.
17. Yuda H, Adachi Y, Taguchi O, Gabazza EC, Hataji O, Fujimoto H, Tamaki S, Nishikubo K, Fukudome K, D'Alessandro-Gabazza CN, et al. Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice. Blood 2004;103:2196-2204.
18. Takagi T, Urawa M, Naito M, Fujiwara A, Ebihara A, Kobayashi T, Kobayashi H, D'Alessandro CN, Gabazza EC, Taguchi O. Protective effect of thrombomodulin in murine model of allergen-asthma. Am J Respir Crit Care Med 2010;181:A5679.
19. Dittman WA, Kumada T, Sadler JE, Majerus PW. The structure and function of mouse thrombomodulin. Phorbol myristate acetate stimulates degradation and synthesis of thrombomodulin without affecting mRNA levels in hemangioma cells. J Biol Chem1988;263:15815-15822.
20. Zheng XX, Steele AW, Nickerson PW, Steurer W, Steiger J, Strom TB. Administration of noncytolytic IL-10/fc in murine models of lipopolysaccharide- induced septic shock and allogeneic islet transplantation. J Immunol 1995;154:5590-5600.
21. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176:1693-1702.
22. Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, et al. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J Exp Med 2002;196:565-577.
23. Myint KM, Yamamoto Y, Doi T, Kato I, Harashima A, Yonekura H, Watanabe T, Shinohara H, Takeuchi M, Tsuneyama K, et al. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes 2006;55:2510-2522.
24. Feuerstein B, Berger TG, Maczek C, Roder C, Schreiner D, Hirsch U, Haendle I, Leisgang W, Glaser A, Kuss O, et al. A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. J Immunol Methods 2000;245:15-29.
25. Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996;184:923-930.
26. Steinkamp JA, Wilson JS, Saunders GC, Stewart CC. Phagocytosis: flow cytometric quantitation with fluorescent microspheres. Science 1982; 215:64-66.
27. Pohajdak B, Gomez J, Orr FW, Khalil N, Talgoy M, Greenberg AH. Chemotaxis of large granular lymphocytes. J Immunol 1986;136:278-284.
28. Kakehashi H, Nishioku T, Tsukuba T, Kadowaki T, Nakamura S, Yamamoto K. Differential regulation of the nature and functions of dendritic cells and macrophages by cathepsin e. J Immunol 2007;179: 5728-5737.
29. Uchiba M, Okajima K, Murakami K, Johno M, Mohri M, Okabe H, Takatsuki K. Rhs-TM prevents ET-induced increase in pulmonary vascular permeability through protein C activation. Am J Physiol 1997;273:L889-L894.
30. Esmon CT. The protein C pathway. Chest 2003;124:26S-32S.
31. Suzuki K, Hayashi T, Nishioka J, Kosaka Y, Zushi M, Honda G, Yamamoto S. A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. J Biol Chem 1989;264:4872-4876.
32. Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M, Uchimura T, Ida N, Yamazaki Y, Yamada S, et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest 2005;115: 1267-1274.
33. Hammad H, de Heer HJ, Soullie T, Angeli V, Trottein F, Hoogsteden HC, Lambrecht BN. Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma. Am J Pathol 2004;164:263-271.
34. Shi CS, Shi GY, Hsiao SM, Kao YC, Kuo KL, Ma CY, Kuo CH, Chang BI, Chang CF, Lin CH, et al. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood 2008; 112:3661-3670.
35. Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I, Chang RJ, Lin JH, Vilander L, Andrews WH, et al. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. J Clin Invest 1992;90:2565-2573.
36. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991;65:618-623.
37. Conway EM, Rosenberg RD. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 1988;8:5588-5592.
38. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN. Characterization of human blood dendritic cell subsets. Blood 2002; 100:4512-4520.
39. Urban BC, Cordery D, Shafi MJ, Bull PC, Newbold CI, Williams TN, Marsh K. The frequency of BDCA3-positive dendritic cells is increased in the peripheral circulation of Kenyan children with severe malaria. Infect Immun 2006;74:6700-6706.
40. Beckebaum S, Zhang X, Chen X, Yu Z, Frilling A, Dworacki G, Grosse-Wilde H, Broelsch CE, Gerken G, Cicinnati VR. Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin Cancer Res 2004;10: 7260-7269.
41. Yerkovich ST, Roponen M, Smith ME, McKenna K, Bosco A, Subrata LS, Mamessier E, Wikstrom ME, Le Souef P, Sly PD, et al. Allergen-enhanced thrombomodulin (blood dendritic cell antigen 3, CD141) expression on dendritic cells is associated with a Th2-skewed immune response. J Allergy Clin Immunol 2009;123:209-216.e4.
42. Bratke K, Kuepper M, Julius P, Lommatzsch M, Virchow JC. Thrombomodulin: a novel player in allergic asthma. J Allergy Clin Immunol 2009;123:1192, author reply 1192-1193.
43. Blomberg S, Eloranta ML, Magnusson M, Alm GV, Ronnblom L. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 2003;48:2524-2532.
44. McCarthy NE, Jones HA, Marks NA, Shiner RJ, Ind PW, Al-Hassi HO, English NR, Murray CM, Lambert JR, Knight SC, et al. Inhaled allergen-driven CD1c up-regulation and enhanced antigen uptake by activated human respiratory-tract dendritic cells in atopic asthma. Clin Exp Allergy 2007;37:72-82.
45. Schulz O, Diebold SS, Chen M, Naslund TI, Nolte MA, Alexopoulou L, Azuma YT, Flavell RA, Liljestrom P, Reis e Sousa C. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 2005; 433:887-892.
46. Orabona C, Puccetti P, Vacca C, Bicciato S, Luchini A, Fallarino F, Bianchi R, Velardi E, Perruccio K, Velardi A, et al. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 2006;107:2846-2854.
47. Poulin LF, Salio M, Griessinger E, Anjos-Afonso F, Craciun L, Chen JL, Keller AM, Joffre O, Zelenay S, Nye E, et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α1 dendritic cells. J Exp Med 2010;207: 1261-1271.